Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis.
Bechdolf A, Müller H, Stützer H, Wagner M, Maier W, Lautenschlager M, Heinz A, de Millas W, Janssen B, Gaebel W, Michel TM, Schneider F, Lambert M, Naber D, Brüne M, Krüger-Özgürdal S, Wobrock T, Riedel M, Klosterkötter J; PREVENT study group. Bechdolf A, et al. Among authors: klosterkotter j. Schizophr Bull. 2011 Sep;37 Suppl 2:S111-21. doi: 10.1093/schbul/sbr083. Schizophr Bull. 2011. PMID: 21860040 Free PMC article. Clinical Trial.
Prevention of First-Episode Psychosis in People at Clinical High Risk: A Randomized Controlled, Multicentre Trial Comparing Cognitive-Behavioral Therapy and Clinical Management Plus Low-Dose Aripiprazole or Placebo (PREVENT).
Bechdolf A, Müller H, Hellmich M, de Millas W, Falkai P, Gaebel W, Gallinat J, Hasan A, Heinz A, Janssen B, Juckel G, Karow A, Krüger-Özgürdal S, Lambert M, Maier W, Meyer-Lindenberg A, Pützfeld V, Rausch F, Schneider F, Stützer H, Wobrock T, Wagner M, Zink M, Klosterkötter J. Bechdolf A, et al. Among authors: klosterkotter j. Schizophr Bull. 2023 Jul 4;49(4):1055-1066. doi: 10.1093/schbul/sbad029. Schizophr Bull. 2023. PMID: 37021666 Free PMC article. Clinical Trial.
Speech Illusions in People at Clinical High Risk for Psychosis Linked to Clinical Outcome.
Hird EJ, Ohmuro N, Allen P, Moseley P, Kempton MJ, Modinos G, Sachs G, van der Gaag M, de Haan L, Gadelha A, Bressan R, Barrantes-Vidal N, Ruhrmann S, Catalan A; EU-GEI High Risk Study; McGuire P. Hird EJ, et al. Schizophr Bull. 2023 Mar 15;49(2):339-349. doi: 10.1093/schbul/sbac163. Schizophr Bull. 2023. PMID: 36516396 Free PMC article.
Deep brain stimulation of the nucleus accumbens in treatment-resistant alcohol use disorder: a double-blind randomized controlled multi-center trial.
Bach P, Luderer M, Müller UJ, Jakobs M, Baldermann JC, Voges J, Kiening K, Lux A, Visser-Vandewalle V; DeBraSTRA study group; Bogerts B, Kuhn J, Mann K. Bach P, et al. Transl Psychiatry. 2023 Feb 8;13(1):49. doi: 10.1038/s41398-023-02337-1. Transl Psychiatry. 2023. PMID: 36755017 Free PMC article. Clinical Trial.
Influence of cannabis use on incidence of psychosis in people at clinical high risk.
Chester LA, Valmaggia LR, Kempton MJ, Chesney E, Oliver D, Hedges EP, Klatsa E, Stahl D, van der Gaag M, de Haan L, Nelson B, McGorry P, Amminger GP, Riecher-Rössler A, Studerus E, Bressan R, Barrantes-Vidal N, Krebs MO, Glenthøj B, Nordentoft M, Ruhrmann S, Sachs G, McGuire P; EU-GEI High Risk Study Group. Chester LA, et al. Psychiatry Clin Neurosci. 2023 Sep;77(9):469-477. doi: 10.1111/pcn.13555. Epub 2023 May 13. Psychiatry Clin Neurosci. 2023. PMID: 37070555 Free PMC article.
[Running amok: Can psychiatry do anything about it?].
Kuhn J, Klosterkötter J. Kuhn J, et al. Among authors: klosterkotter j. Fortschr Neurol Psychiatr. 2023 May;91(5):188-190. doi: 10.1055/a-2054-0147. Epub 2023 May 16. Fortschr Neurol Psychiatr. 2023. PMID: 37192609 German. No abstract available.
Bridging the phenomenological gap between predictive basic-symptoms and attenuated positive symptoms: a cross-sectional network analysis.
Müller H, Betz LT, Kambeitz J, Falkai P, Gaebel W, Heinz A, Hellmich M, Juckel G, Lambert M, Meyer-Lindenberg A, Schneider F, Wagner M, Zink M, Klosterkötter J, Bechdolf A. Müller H, et al. Among authors: klosterkotter j. Schizophrenia (Heidelb). 2022 Aug 24;8(1):68. doi: 10.1038/s41537-022-00274-4. Schizophrenia (Heidelb). 2022. PMID: 36002447 Free PMC article.
Differential trajectories of tobacco smoking in people at ultra-high risk for psychosis: Associations with clinical outcomes.
Schirmbeck F, van der Ven E, Boyette LL, McGuire P, Valmaggia LR, Kempton MJ, van der Gaag M, Riecher-Rössler A, Barrantes-Vidal N, Nelson B, Krebs MO, Ruhrmann S, Sachs G, Rutten BPF, Nordentoft M; EU-GEI High Risk Study Group; de Haan L, Vermeulen JM. Schirmbeck F, et al. Front Psychiatry. 2022 Jul 22;13:869023. doi: 10.3389/fpsyt.2022.869023. eCollection 2022. Front Psychiatry. 2022. PMID: 35942478 Free PMC article.
The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for Psychosis.
Tognin S, Richter A, Kempton MJ, Modinos G, Antoniades M, Azis M, Allen P, Bossong MG, Perez J, Pantelis C, Nelson B, Amminger P, Riecher-Rössler A, Barrantes-Vidal N, Krebs MO, Glenthøj B, Ruhrmann S, Sachs G, Rutten BPF, de Haan L, van der Gaag M; EU-GEI High Risk Study Group; Valmaggia LR, McGuire P. Tognin S, et al. Schizophr Bull Open. 2022 Jun 20;3(1):sgac040. doi: 10.1093/schizbullopen/sgac040. eCollection 2022 Jan. Schizophr Bull Open. 2022. PMID: 35903803 Free PMC article.
309 results